Showing results (231-240 of 550) with videos related to

Sort By:
Pageof 55
Scientific Reports|January 26, 2019
PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung CancerYang Wang, Tae Hyun Kim, Shamileh Fouladdel, et al.
Molecular Cancer Therapeutics|December 3, 2020
Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination-Proficient Pancreatic CancerLeslie A Parsels, Carl G Engelke, Joshua Parsels, et al.
Molecular Cancer Therapeutics|February 2, 2011
Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspasesJie Yang, Donna McEachern, Wenyan Li, et al.
Practical Radiation Oncology|January 10, 2016
Enhancing safety and quality through preplanning peer review for patients undergoing stereotactic body radiation therapyMartha M Matuszak, Scott W Hadley, Mary Feng, et al.
Cancers|April 25, 2020
Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized MedicineLianette Rivera-Báez, Ines Lohse, Eric Lin, et al.
Translational Lung Cancer Research|December 9, 2017
Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparationFeng-Ming Spring Kong, Lujun Zhao, Luhua Wang, et al.
Translational Oncology|August 3, 2013
Stereotactic body radiation therapy for primary and metastatic liver tumorsErqi Liu, Matthew H Stenmark, Matthew J Schipper, et al.
Gastroenterology|January 9, 2014
Antibody against CD44s inhibits pancreatic tumor initiation and postradiation recurrence in miceLing Li, Xinbao Hao, Jun Qin, et al.
Molecular Cancer Therapeutics|March 14, 2012
Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancerTerence M Williams, Athena R Flecha, Paul Keller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C/CDK1 and homologous recombination repairDongping Wei, Leslie A Parsels, David Karnak, et al.
Pageof 55